Evidence map›Paper›PMID 36247205›Full record

ArticleAdvances in urology2022

Outcomes of Top-Down Holmium Laser Enucleation of Prostate for Recurrent/Residual Benign Prostatic Hyperplasia: One-Year Follow-Up.

Ahmed S Zakaria, Amr Hodhod, Loay Abbas, Moustafa Fathy, Ruba Abdul Hadi, Waleed Shabana, Anastasia Alexandra MacDonald, Ahmed Gamaleldin, Mohamed Abdallah, Mohamed Elgharbawy and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ahmed S ZakariaUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Amr HodhodUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Loay AbbasUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.ORCID https://orcid.org/0000-0001-7514-7005
Moustafa FathyUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Ruba Abdul HadiUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Waleed ShabanaUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Anastasia Alexandra MacDonaldUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Ahmed GamaleldinUrology Department, Menoufia University, Shebin Elkom, Egypt.
Mohamed AbdallahUrology Department, Menoufia University, Shebin Elkom, Egypt.ORCID https://orcid.org/0000-0003-0377-5867
Mohamed ElgharbawyUrology Department, Menoufia University, Shebin Elkom, Egypt.
Abdulrahman AhmadUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Adam RoosUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Ahmed KotbUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Walid ShahrourUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Hazem ElmansyUrology Department, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.ORCID https://orcid.org/0000-0003-3601-4626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: We carried out a retrospective analysis of patients who underwent top-down HoLEP for the management of recurrent BPH at our institution. Patients who had previously undergone TURP were assigned to group I, while those with no history of prostate surgery were allocated to group II. Preoperative clinical characteristics, enucleation time, resected tissue weight, morcellation time, energy used, and intraoperative and postoperative complications were recorded and statistically analyzed. Patients were followed up postoperatively at 1, 3, 6, and 12 months. The evaluation included the International Prostate Symptom Score (IPSS), quality of life assessment (QoL), maximum urinary flow rate ( Results: Two hundred and sixty-nine patients were included in this study. Group I consisted of 68 patients with recurrent BPH, while group II included 201 patients. There were no statistically significant differences in preoperative characteristics between both groups. The median enucleation time for group I (67.5 min (25-200)) was not significantly longer than that for group II (60 min (19-165) ( Conclusions: For managing recurrent and nonrecurrent cases of BPH, top-down HoLEP is safe with comparable urinary functional outcomes. Patients with a history of previous prostate surgery can be counselled that their prior transurethral procedure does not reduce the benefits of HoLEP.

Identifiers

PMID36247205
PMCPMC9553753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.